Talarico, M.C.R.; Derchain, S.; da Silva, L.F.; Sforça, M.L.; Rocco, S.A.; Cardoso, M.R.; Sarian, L.O.
Metabolomic Profiling of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy for Predicting Disease-Free and Overall Survival. Int. J. Mol. Sci. 2024, 25, 8639.
https://doi.org/10.3390/ijms25168639
AMA Style
Talarico MCR, Derchain S, da Silva LF, Sforça ML, Rocco SA, Cardoso MR, Sarian LO.
Metabolomic Profiling of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy for Predicting Disease-Free and Overall Survival. International Journal of Molecular Sciences. 2024; 25(16):8639.
https://doi.org/10.3390/ijms25168639
Chicago/Turabian Style
Talarico, Maria CecÃlia Ramiro, Sophie Derchain, Lucas Ferreira da Silva, MaurÃcio L. Sforça, Silvana A. Rocco, Marcella R. Cardoso, and LuÃs Otávio Sarian.
2024. "Metabolomic Profiling of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy for Predicting Disease-Free and Overall Survival" International Journal of Molecular Sciences 25, no. 16: 8639.
https://doi.org/10.3390/ijms25168639
APA Style
Talarico, M. C. R., Derchain, S., da Silva, L. F., Sforça, M. L., Rocco, S. A., Cardoso, M. R., & Sarian, L. O.
(2024). Metabolomic Profiling of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy for Predicting Disease-Free and Overall Survival. International Journal of Molecular Sciences, 25(16), 8639.
https://doi.org/10.3390/ijms25168639
